optral Competitors

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling almost 12 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets (September 30, 2025). For its customers, ZEISS develops, produces, and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses, and binoculars. With a portfolio aligned with future growth areas like digitalization, healthcare, and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 15 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future. With over 46,600 employees, ZEISS is active globally in around 50 countries with more than 60 sales and service locations, around 40 research and development facilities, and 30 production facilities worldwide. Learn more about ZEISS: www.zeiss.com/about Data privacy: www.zeiss.com/data-protection Imprint: www.zeiss.com/publisher This is ZEISS's official LinkedIn account. It follows the ZEISS Netiquette: www.zeiss.com/netiquette

When a five-year-old boy was blinded after a regular eye exam failed to spot a retinal detachment, his father made it his life’s work to help eye care professionals by revolutionising retinal imaging. Optos was founded by Douglas Anderson with the goal to make a patient-friendly device to capture a digital ultra-widefield image of the retina. Today, millions of patients around the world have benefited from optomap® retinal imaging. You will find optomap systems in many independent High Street optometrists, as well as eye clinics at Great Ormond Street Hospital in London and Harvard Medical Center in Massachusetts. Our core products produce high resolution optomap images of 82% or 200◦ of the retina, something no other imaging device is capable of in a single comfortable capture. The most recent innovation from Optos integrates ultra-widefield retinal imaging and image-guided Optical Coherence Tomography (OCT). This combined device facilitates the early detection, management and effective treatment of disorders and diseases evidenced in the retina such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration. More than 1,000 published and ongoing clinical trials as well as thousands of case studies and testimonials show the long-term value of optomap imaging and OCT in diagnosis, treatment planning, and patient engagement. As a division of Nikon Co. Ltd, Japan since 2015, Optos is approaching its 30th anniversary and proud to be recognized as a leading provider of devices to eye care professionals to provide a more complete approach to patient care.

Heidelberg Engineering pioneers imaging and data technologies to optimize ophthalmic solutions that empower eye care professionals who want to improve the holistic health of patients. Since 1990, uncompromising quality and education play a large part in fostering the diagnostic confidence that has become synonymous with the global brand. The SPECTRALIS multi-modal imaging platform for the posterior segment offers unparalleled retinal image quality and reproducibility, supporting the diagnosis and treatment of glaucoma, AMD, diabetic retinopathy and many other retinal diseases. The ANTERION multi-disciplinary imaging platform is an easy-to-use, all-in-one anterior segment solution, with all measurements based solely on high-quality OCT technology. The HEYEX 2 image management and device integration platform manages all diagnostic images and supports workflow efficiency with standardized data and interfaces. Legal Information Heidelberg Engineering GmbH Max-Jarecki-Straße 8 69115 Heidelberg Germany Phone: 0049 62 21-64 63-0 Fax: 0049 62 21-64 63 62 eMail: info@HeidelbergEngineering.com Trade Register: Mannheim, HRB 334163 USt-Id.No. DE143445065 WEEE-Reg.-No. DE 16429130 Managing Directors: Arianna Schoess Vargas Kfir Azoulay © Heidelberg Engineering GmbH Privacy Policy Social Media: https://www.heidelbergengineering.com/int/privacy-policy-for-the-social-media-appearances-of-heidelberg-engineering-gmbh/ Online Dispute Resolution: http://ec.europa.eu/consumers/odr/ Disputes shall not be settled by a consumer arbitration body.